Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus

BMC Genomics
Judith HübscherBrigitte Berger-Bächi

Abstract

Synthesis of the Staphylococcus aureus peptidoglycan pentaglycine interpeptide bridge is catalyzed by the nonribosomal peptidyl transferases FemX, FemA and FemB. Inactivation of the femAB operon reduces the interpeptide to a monoglycine, leading to a poorly crosslinked peptidoglycan. femAB mutants show a reduced growth rate and are hypersusceptible to virtually all antibiotics, including methicillin, making FemAB a potential target to restore beta-lactam susceptibility in methicillin-resistant S. aureus (MRSA). Cis-complementation with wild type femAB only restores synthesis of the pentaglycine interpeptide and methicillin resistance, but the growth rate remains low. This study characterizes the adaptations that ensured survival of the cells after femAB inactivation. In addition to slow growth, the cis-complemented femAB mutant showed temperature sensitivity and a higher methicillin resistance than the wild type. Transcriptional profiling paired with reporter metabolite analysis revealed multiple changes in the global transcriptome. A number of transporters for sugars, glycerol, and glycine betaine, some of which could serve as osmoprotectants, were upregulated. Striking differences were found in the transcription of several ge...Continue Reading

References

Nov 5, 1989·Journal of Molecular Biology·H J SchreierA L Sonenshein
Feb 1, 1989·The Journal of Antimicrobial Chemotherapy·Brigitte Berger-BächiF H Kayser
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·L K JolliffeU N Streips
Nov 1, 1994·Analytical Biochemistry·A L CheungV A Fischetti
Aug 25, 1995·Nucleic Acids Research·S K Goda, N P Minton
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·D A BeauregardD J Knowles
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·Lewis V WraySusan H Fisher
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y LuR L Switzer
Mar 17, 1999·FEMS Microbiology Letters·M TschierskeBrigitte Berger-Bächi
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·S RohrerBrigitte Berger-Bächi
Jan 11, 2001·FEMS Microbiology Letters·Markus BischoffBrigitte Berger-Bächi
Jul 18, 2003·Journal of Bacteriology·Emmanuel F MongodinGordon L Archer
Nov 18, 2003·Journal of Bacteriology·Christian KohlerSusanne Engelmann
Jan 22, 2004·FEMS Immunology and Medical Microbiology·Ambrose L CheungYan-Qiong Xiong
May 6, 2004·Journal of Bacteriology·Nadine McCallumBrigitte Berger-Bächi
Jul 3, 2004·Journal of Bacteriology·Karen E BeenkenMark S Smeltzer
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kiran Raosaheb Patil, Jens Nielsen
May 5, 2005·Applied and Environmental Microbiology·Alexandra ReschFriedrich Götz
Sep 13, 2005·Biotechnology and Bioengineering·Matthias HeinemannSven Panke
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Elizabeth FullerTony Fawcett
Mar 21, 2006·Journal of Bacteriology·Mohammed Terrak, Martine Nguyen-Distèche
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Gordon K Smyth
Jul 25, 2006·Molecular Microbiology·Anthony R RichardsonFerric C Fang
Nov 15, 2006·Antimicrobial Agents and Chemotherapy·Caroline KusumaJohn F Kokai-Kun
Dec 16, 2006·FEMS Microbiology Letters·Lilia MichailovaNadya Markova

Citations

Jun 8, 2010·Journal of Medicinal Chemistry·Jed F Fisher, Shahriar Mobashery
Feb 17, 2010·The Journal of Antimicrobial Chemotherapy·Stamatina GiannouliAthanassios Tsakris
May 11, 2010·Cold Spring Harbor Perspectives in Biology·Thomas J SilhavySuzanne Walker
Aug 13, 2008·Antimicrobial Agents and Chemotherapy·Alexandros IkonomidisSpyros Pournaras
May 20, 2009·BMC Microbiology·Kati SeidlBrigitte Berger-Bächi
Jul 4, 2009·Oral Microbiology and Immunology·X D LiuL H Guo
Jan 11, 2014·Molecular Microbiology·Robert D TurnerSimon J Foster
Aug 18, 2012·Molecular BioSystems·Haihong HaoZonghui Yuan
Mar 23, 2019·Scientific Reports·João M MonteiroMariana G Pinho
Dec 30, 2020·Chemical Reviews·Jed F Fisher, Shahriar Mobashery
Jul 20, 2019·Microbiology Spectrum·Rita Sobral, A Tomasz

Methods Mentioned

BETA
Scanning electron microscopy
chip
amidation
dot blot
phosphotransferase
PCR
chips

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacterial Transport Proteins (ASM)

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Bacterial Transport Proteins

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

ABC Transporters & Multidrug Resistance

ABC Transporters or ATP-Binding Cassette Transporters are responsible for pumping out antibiotics in the cell and can lead to multidrug resistance in bacteria. Discover the latest research on ABC Transporters & Multidrug Resistance here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.